← Back to Search

Hormone Therapy

high-dose intranasal oxytocin for Tinnitus

N/A
Waitlist Available
Led By Lawrence Newman, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 9
Awards & highlights

Study Summary

This trial will test if oxytocin can help treat tinnitus by reducing severity and disability.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 9
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 9 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tinnitus

Side effects data

From 2023 Phase 4 trial • 108 Patients • NCT04028765
6%
Blood transfusion
100%
80%
60%
40%
20%
0%
Study treatment Arm
Oral Misoprostol-Mothers
Oxytocin-Fetus/Neonate
Oral Misoprostol-Fetus/Neonate
Oxytocin-Mothers

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: high-dose intranasal oxytocinExperimental Treatment1 Intervention
Subjects will be asked to use one spray in one nostril 4 times daily (9AM, 1PM, 5PM and 9 PM). Subjects will take 4 sprays daily of oxytocin for the entire study.
Group II: Nasal sprayPlacebo Group1 Intervention
Subjects swill be asked to use one spray in one nostril 4 times daily (9AM, 1PM, 5PM and 9 PM). The spray can be taken with or without food. Subjects will take 4 sprays daily of the placebo for the entire study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oxytocin
2016
Completed Phase 4
~2340

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,373 Previous Clinical Trials
841,090 Total Patients Enrolled
Lawrence Newman, MDPrincipal InvestigatorNYU Langone
~6 spots leftby Jun 2025